主页 / 资源 / 按需随选的网络研讨会 / Combining active pharmaceutical ingredients (APIs): MPT Development & Regulatory Considerations
Combining active pharmaceutical ingredients (APIs): MPT Development & Regulatory Considerations
六月 17, 2021
按需随选的网络研讨会

This fourth webinar in the “Let’s Talk MPTs” learning series will provide MPT product developers and other stakeholders an overview of clinical development and regulatory considerations when developing products that combine one or more active pharmaceutical ingredients (APIs) into an MPT product.

Speakers

• Deven Shah – Chemistry, Manufacturing, & Control (CM&C) Lead at Certara
• Kevin Hershberger – Vice President of Integrated Drug Development at Certara
• Tamra Goodrow – Regulatory Consultant & Principal at Deer Run Regulatory Consulting

返回顶部
Powered by Translations.com GlobalLink OneLink Software